RUNX1 and cancer

Bae, 2020, Tour d'Horizon of recent advances in RUNX family gene research, Mol. Cells, 43, 97 Mevel, 2019, RUNX transcription factors: orchestrators of development, Development, 146, 10.1242/dev.148296 Ito, 2015, The RUNX family: developmental regulators in cancer, Nat. Rev. Cancer, 15, 81, 10.1038/nrc3877 Dowdy, 2010, Definitive hematopoiesis requires Runx1 C-terminal-mediated subnuclear targeting and transactivation, Hum. Mol. Genet., 19, 1048, 10.1093/hmg/ddp568 Yamagata, 2005, Runx1/AML1 in normal and abnormal hematopoiesis, Int. J. Hematol., 82, 1, 10.1532/IJH97.05075 Lian, 2004, Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors, Crit. Rev. Eukaryot. Gene Expr., 14, 1, 10.1615/CritRevEukaryotGeneExpr.v14.i12.10 Lian, 2003, Runx2/Cbfa1: a multifunctional regulator of bone formation, Curr. Pharm. Des., 9, 2677, 10.2174/1381612033453659 Komori, 2003, Requisite roles of Runx2 and cbfb in skeletal development, J. Bone Miner. Metab., 21, 193 Fukamachi, 2006, Runx3 controls growth and differentiation of gastric epithelial cells in mammals, Dev. Growth Differ., 48, 1, 10.1111/j.1440-169X.2006.00832.x Tahirov, 2001, Structural analyses of DNA recognition by the AML1/Runx-1 runt domain and its allosteric control by CBFbeta, Cell, 104, 755, 10.1016/S0092-8674(01)00271-9 Miyoshi, 1991, t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1, Proc. Natl. Acad. Sci. U. S. A., 88, 10431, 10.1073/pnas.88.23.10431 Ito, 2004, Oncogenic potential of the RUNX gene family: 'overview', Oncogene, 23, 4198, 10.1038/sj.onc.1207755 Ghozi, 1996, Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions, Proc. Natl. Acad. Sci. U. S. A., 93, 1935, 10.1073/pnas.93.5.1935 Miyoshi, 1995, Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia, Nucleic Acids Res., 23, 2762, 10.1093/nar/23.14.2762 Hong, 2019, RUNX1-dependent mechanisms in biological control and dysregulation in cancer, J. Cell. Physiol., 234, 8597, 10.1002/jcp.27841 Taniuchi, 2012, Runx1: no longer just for leukemia, EMBO J., 31, 4098, 10.1038/emboj.2012.282 Bera, 2019, RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia, J. Hematol. Oncol., 12, 104, 10.1186/s13045-019-0789-3 Adnan Awad, 2021, RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses, Leukemia, 35, 1087, 10.1038/s41375-020-01011-5 Ni, 2021, Clinical characteristics of acute myeloid leukemia patients with RUNX1 gene mutation, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 29, 1411 Rehman, 2021, RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients, SaudiJ. Biol. Sci., 28, 4845, 10.1016/j.sjbs.2021.07.012 Yang, 2020, RUNX1 gene mutations are associated with adverse prognosis of patients with acute myeloidleukemia, Nan Fang Yi Ke Da Xue Xue Bao, 40, 1601 Matheny, 2007, Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles, EMBO J., 26, 1163, 10.1038/sj.emboj.7601568 Shah, 2021, Identifying genomic alterations in patients with stage IV breast cancer using MammaSeq: an international collaborative study, Clin. Breast Cancer, 21, 210, 10.1016/j.clbc.2020.08.009 Pang, 2017, Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer, Mod. Pathol., 30, 952, 10.1038/modpathol.2017.21 Malik, 2019, The transcription factor CBFB suppresses breast cancer through orchestrating translation and transcription, Nat. Commun., 10, 2071, 10.1038/s41467-019-10102-6 P.-C.A.o.W.G. Consortium, 2020, Pan-cancer analysis of whole genomes, Nature, 578, 82, 10.1038/s41586-020-1969-6 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov., 2, 401, 10.1158/2159-8290.CD-12-0095 Gao, 2013, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal., 6, pl1, 10.1126/scisignal.2004088 Abe, 2020, Truncated RUNX1 generated by the fusion of RUNX1 to antisense GRIK2 via a cryptic chromosome translocation enhances sensitivity to granulocyte Colony-stimulating factor, Cytogenet. Genome Res., 160, 255, 10.1159/000508012 Yun, 2019, Elucidation of novel therapeutic targets for acute myeloid leukemias with RUNX1-RUNX1T1 fusion, Int. J. Mol. Sci., 20, 10.3390/ijms20071717 Liu, 2019, RUNX1 inhibits proliferation and induces apoptosis of t(8;21) leukemia cells via KLF4-mediated transactivation of P57, Haematologica, 104, 1597, 10.3324/haematol.2018.192773 Chen, 2019, The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter, FEBS J., 286, 901, 10.1111/febs.14751 Gao, 2017, Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer, Nat. Commun., 8, 228, 10.1038/s41467-017-00244-w Kim, 2018, Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing, Cell, 173, 879, 10.1016/j.cell.2018.03.041 Azizi, 2018, Single-cell map of diverse immune phenotypes in the breast tumor microenvironment, Cell, 174, 1293, 10.1016/j.cell.2018.05.060 Chung, 2017, Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer, Nat. Commun., 8, 15081, 10.1038/ncomms15081 Peng, 2020, Single-cell RNA sequencing of a postmenopausal normal breast tissue identifies multiple cell types that contribute to breast cancer, Cancers (Basel), 12, 10.3390/cancers12123639 Uhlen, 2005, A human protein atlas for normal and cancer tissues based on antibody proteomics, Mol. Cell. Proteomics, 4, 1920, 10.1074/mcp.M500279-MCP200 Lin, 2015, Ghrelin promotes renal cell carcinoma metastasis via snail activation and is associated with poor prognosis, J. Pathol., 237, 50, 10.1002/path.4552 Li, 2019, RUNX1 promotes tumour metastasis by activating the Wnt/beta-catenin signalling pathway and EMT in colorectal cancer, J. Exp. Clin. Cancer Res., 38, 334, 10.1186/s13046-019-1330-9 Wang, 2020, Knockdown of circ_0000512 inhibits cell proliferation and promotes apoptosis in colorectal cancer by regulating miR-296-5p/RUNX1 axis, Onco Targets Ther., 13, 7357, 10.2147/OTT.S250495 Chang, 2020, lncRNA TTNAS1 upregulates RUNX1 to enhance glioma progression via sponging miR27b3p, Oncol. Rep., 44, 1064, 10.3892/or.2020.7684 Zhao, 2019, RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFbeta pathway-dependent manner, Cell Death Dis., 10, 877, 10.1038/s41419-019-2108-x Feng, 2021, Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma, Exp. Biol. Med. (Maywood), 246, 538, 10.1177/1535370220969663 Liu, 2020, Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferation, Genomics, 112, 5343, 10.1016/j.ygeno.2020.11.010 Liu, 2020, The lncRNA RUNX1-IT1 regulates C-FOS transcription by interacting with RUNX1 in the process of pancreatic cancer proliferation, migration and invasion, Cell Death Dis., 11, 412, 10.1038/s41419-020-2617-7 Li, 2021, RUNX1 regulates the proliferation and chemoresistance of colorectal cancer through the hedgehog signaling pathway, J. Cancer, 12, 6363, 10.7150/jca.51338 Chen, 2019, Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients, Pathol. Res. Pract., 215, 10.1016/j.prp.2019.152686 Fu, 2019, Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis, PeerJ, 7, 10.7717/peerj.7854 Qi, 2020, Effects of miR-18a on proliferation and apoptosis of gastric cancer cells by regulating RUNX1, Eur. Rev. Med. Pharmacol. Sci., 24, 9957 Han, 2021, Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression, Eur. J. Clin. Investig., 51, 10.1111/eci.13592 Hong, 2020, Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo, J. Exp. Clin. Cancer Res., 39, 52, 10.1186/s13046-020-01558-2 Lan, 2021, The expression and clinical significance of signal transducer and activator of transcription 3, tumor necrosis factor alpha induced protein 8-like 2, and runt-related transcription factor 1 in breast cancer patients, Gland Surg., 10, 1125, 10.21037/gs-21-108 Zhu, 2009, The UCSC cancer genomics browser, Nat. Methods, 6, 239, 10.1038/nmeth0409-239 Soares, 2021, Prognostic importance of RUNX1 expression for head and neck adenoid cystic carcinoma, Oral Dis., 27, 266, 10.1111/odi.13522 Rooney, 2020, RUNX1 is a driver of renal cell carcinoma correlating with clinical outcome, Cancer Res., 80, 2325, 10.1158/0008-5472.CAN-19-3870 Wang, 2021, RUNX1 and REXO2 are associated with the heterogeneity and prognosis of IDH wild type lower grade glioma, Sci. Rep., 11, 11836, 10.1038/s41598-021-91382-1 Hong, 2018, Suppression of breast cancer stem cells and tumor growth by the RUNX1 transcription factor, Mol. Cancer Res., 16, 1952, 10.1158/1541-7786.MCR-18-0135 Uhlen, 2015, ProteomicsTissue-based map of the human proteome, Science, 347, 1260419, 10.1126/science.1260419 Uhlen, 2010, Towards a knowledge-based human protein atlas, Nat. Biotechnol., 28, 1248, 10.1038/nbt1210-1248 Thul, 2017, A subcellular map of the human proteome, Science, 356, 10.1126/science.aal3321 Uhlen, 2017, A pathology atlas of the human cancer transcriptome, Science, 357, 10.1126/science.aan2507 Gyorffy, 2009, Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients, Breast Cancer Res. Treat., 118, 433, 10.1007/s10549-008-0242-8 Xue, 2021, RUNX1/miR-582-5p pathway regulates the tumor progression in clear cell renal cell carcinoma by targeting COL5A1, Front. Oncol., 11, 10.3389/fonc.2021.610992 Xu, 2020, RUNX1-activated upregulation of lncRNA RNCR3 promotes cell proliferation, invasion, and suppresses apoptosis in colorectal cancer via miR-1301-3p/AKT1 axis in vitro and in vivo, Clin. Transl. Oncol., 22, 1762, 10.1007/s12094-020-02335-5 Wang, 2020, COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-src signaling, J. Exp. Clin. Cancer Res., 39, 148, 10.1186/s13046-020-01650-7 Zhen, 2020, RUNX1 and CBFbeta-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development, Blood, 136, 2373, 10.1182/blood.2020007747 Mill, 2019, RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1, Blood, 134, 59, 10.1182/blood.2018893982 Montano, 2020, ETV6/RUNX1 fusion gene abrogation decreases the oncogenicity of tumour cells in a preclinical model of acute lymphoblastic leukaemia, Cells, 9, 10.3390/cells9010215 He, 2019, Runt-related transcription factor 1 contributes to lung cancer development by binding to tartrate-resistant acid phosphatase 5, Cell Cycle, 18, 3404, 10.1080/15384101.2019.1678966 Liu, 2020, Upregulation of RUNX1 suppresses proliferation and migration through repressing VEGFA expression in hepatocellular carcinoma, Pathol. Oncol. Res., 26, 1301, 10.1007/s12253-019-00694-1 Sangpairoj, 2017, RUNX1 regulates migration, invasion, and angiogenesis via p38 MAPK pathway in human glioblastoma, Cell. Mol. Neurobiol., 37, 1243, 10.1007/s10571-016-0456-y Zhang, 2020, SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression, Theranostics, 10, 4290, 10.7150/thno.41008 Dhadve, 2020, Decoding molecular interplay between RUNX1 and FOXO3a underlying the pulsatile IGF1R expression during acquirement of chemoresistance, Biochim. Biophys. Acta Mol. Basis Dis., 1866, 10.1016/j.bbadis.2020.165754 Debaize, 2018, Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation, Nucleic Acids Res., 46, 11214, 10.1093/nar/gky756 Wesely, 2020, Acute myeloid leukemia iPSCs reveal a role for RUNX1 in the maintenance of human leukemia stem cells, Cell Rep., 31, 10.1016/j.celrep.2020.107688 Redondo Monte, 2020, ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells, Oncogene, 39, 3195, 10.1038/s41388-020-1209-4 Fritz, 2020, RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells, J. Cell. Physiol., 235, 7261, 10.1002/jcp.29625 Gerritsen, 2019, RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs, Blood Adv., 3, 320, 10.1182/bloodadvances.2018024422 Kulkarni, 2018, RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer, Oncotarget, 9, 14175, 10.18632/oncotarget.24419 Hou, 2021, YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect, Cell Death Differ., 28, 3105, 10.1038/s41418-021-00804-0 Simeoni, 2021, Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia, Cell Rep., 36, 10.1016/j.celrep.2021.109725 Rada, 2021, Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases, Commun. Biol., 4, 950, 10.1038/s42003-021-02481-8